Ofloxacin 0.3% ear drops 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,324
Award facts
- Contract value 100% obligated
- $1,323.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,323.83 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of Ofloxacin 0.3% ear drops (5ml) on January 20, 2026, with an ultimate completion date of January 21, 2026. The award carries no set-aside designation and was competitively awarded. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order is executed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which holds the parent IDC with the Defense Logistics Agency. The delivery order for ofloxacin ear drops represents a routine pharmaceutical supply transaction typical of the company's extensive portfolio of medical product deliveries to the Defense Logistics Agency, covering everything from specialty medications and generic drugs to vaccines and medical devices across multiple therapeutic domains. Such orders support the medical supply chain serving Defense Health Agency facilities, the U.S. Coast Guard, and other federal government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQU8L?
SPE2DR26FQU8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU8L worth?
The government has obligated $1,324 on SPE2DR26FQU8L.
Is contract SPE2DR26FQU8L an order under another contract?
Yes. SPE2DR26FQU8L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU8L competed?
The extent of competition for SPE2DR26FQU8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award